512 related articles for article (PubMed ID: 10565811)
41. Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study.
Okamoto S; Takahashi S; Tanosaki R; Sakamaki H; Onozawa Y; Oh H; Miyawaki S; Kimura Y; Toyama K; Ikeda Y; Asano S
Bone Marrow Transplant; 1996 May; 17(5):679-83. PubMed ID: 8733681
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.
Eglen RM; Lee CH; Smith WL; Johnson LG; Clark R; Whiting RL; Hegde SS
Br J Pharmacol; 1995 Feb; 114(4):860-6. PubMed ID: 7773547
[TBL] [Abstract][Full Text] [Related]
43. Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.
Cubeddu LX; O'Connor DT; Hoffmann I; Parmer RJ
Br J Cancer; 1995 Oct; 72(4):1033-8. PubMed ID: 7547218
[TBL] [Abstract][Full Text] [Related]
44. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Rojas C; Stathis M; Thomas AG; Massuda EB; Alt J; Zhang J; Rubenstein E; Sebastiani S; Cantoreggi S; Snyder SH; Slusher B
Anesth Analg; 2008 Aug; 107(2):469-78. PubMed ID: 18633025
[TBL] [Abstract][Full Text] [Related]
45. The relationship between parameters of serotonin metabolism and emetogenic potential of platinum-based chemotherapy regimens.
du Bois A; Vach W; Siebert C; Holy R; Ledergerber M; Wechsel U; Kriesinger-Schroeder H
Support Care Cancer; 1997 May; 5(3):212-8. PubMed ID: 9176967
[TBL] [Abstract][Full Text] [Related]
46. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
[TBL] [Abstract][Full Text] [Related]
47. The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat.
Turvill JL; Connor P; Farthing MJ
Br J Pharmacol; 2000 Jul; 130(5):1031-6. PubMed ID: 10882387
[TBL] [Abstract][Full Text] [Related]
48. Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release.
Stenfors C; Ross SB
Psychopharmacology (Berl); 2004 Mar; 172(2):119-28. PubMed ID: 14735290
[TBL] [Abstract][Full Text] [Related]
49. Increase in serotonin levels in the dog ileum and blood by cisplatin as measured by microdialysis.
Fukui H; Yamamoto M; Ando T; Sasaki S; Sato S
Neuropharmacology; 1993 Oct; 32(10):959-68. PubMed ID: 8295718
[TBL] [Abstract][Full Text] [Related]
50. [Determination of plasma serotonins level in patients with pregnancy induced hypertension].
Zhao W; Zhao L; Zhao W
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):406-8. PubMed ID: 11360650
[TBL] [Abstract][Full Text] [Related]
51. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
[TBL] [Abstract][Full Text] [Related]
52. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
53. Involvement of NMDA receptor mechanisms in the modulation of serotonin release in the lateral parabrachial nucleus in the rat.
Tanaka J; Miyakubo H; Kawakami A; Hayashi Y; Nomura M
Brain Res Bull; 2006 Dec; 71(1-3):311-5. PubMed ID: 17113961
[TBL] [Abstract][Full Text] [Related]
54. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
[TBL] [Abstract][Full Text] [Related]
55. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
Mitani H; Shirayama Y; Yamada T; Kawahara R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
[TBL] [Abstract][Full Text] [Related]
56. Interaction of the antiemetics ondansetron and granisetron with the cytotoxicity induced by irradiation, epirubicin, bleomycin, estramustine, and cisplatin in vitro.
Behnam Motlagh P; Henriksson R; Grankvist K
Acta Oncol; 1995; 34(6):871-5. PubMed ID: 7576757
[TBL] [Abstract][Full Text] [Related]
57. In vivo/ex vivo and behavioural study on central effects of 5-HT1B/1D and 5-HT1A antagonists in guinea pigs.
Rex A; Voigt JP; Wicke KM; Fink H
Pharmacol Biochem Behav; 2008 Jan; 88(3):196-204. PubMed ID: 17888505
[TBL] [Abstract][Full Text] [Related]
58. Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.
Cubeddu LX; O'Connor DT; Parmer RJ
J Clin Oncol; 1995 Mar; 13(3):681-7. PubMed ID: 7533826
[TBL] [Abstract][Full Text] [Related]
59. Serotonin in the control of blood pressure and ultrafiltration in CAPD.
Dimitriadis A; Antoniou S; Malaka E
Adv Perit Dial; 1990; 6():220-3. PubMed ID: 1710499
[TBL] [Abstract][Full Text] [Related]
60. Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
Christofides J; Bridel M; Egerton M; Mackay GM; Forrest CM; Stoy N; Darlington LG; Stone TW
J Neurochem; 2006 May; 97(4):1078-88. PubMed ID: 16573644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
